Analysis of the latest Medicare data shows anesthesia and pain management groups received in 2015 nearly $47 million for G0431 (Drug screen, qualitative; multiple drug classes by high complexity test method [e.g., immunoassay, enzyme assay], per patient encounter).
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.